Related Experiment Video
Updated: Feb 12, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long non-coding RNAs in melanoma
Xin Yu1, Heyi Zheng1, Gary Tse2
1Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract:
Melanoma is the most lethal cutaneous cancer with a highly aggressive and metastatic phenotype. While recent genetic and epigenetic studies have shed new insights into the mechanism of melanoma development, the involvement of regulatory non-coding RNAs remain unclear. Long non-coding RNAs (lncRNAs) are a group of endogenous non-protein-coding RNAs with the capacity to regulate gene expression at multiple levels. Recent evidences have shown that lncRNAs can regulate many cellular processes, such as cell proliferation, differentiation, migration and invasion. In the melanoma, deregulation of a number of lncRNAs, such as HOTAIR, MALAT1, BANCR, ANRIL, SPRY-IT1 and SAMMSON, have been reported. Our review summarizes the functional role of lncRNAs in melanoma and their potential clinical application for diagnosis, prognostication and treatment.
Insights
Long non-coding RNAs (lncRNAs) play a key role in melanoma, a lethal skin cancer. This review explores their function and potential for diagnosing, prognosing, and treating melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma is an aggressive skin cancer with a high metastatic potential.
- While genetic and epigenetic factors are studied, the role of regulatory non-coding RNAs in melanoma is not well understood.
- Long non-coding RNAs (lncRNAs) are regulators of gene expression involved in cellular processes like proliferation and migration.
Purpose of the Study:
- To review the functional roles of lncRNAs in melanoma development and progression.
- To explore the potential clinical applications of lncRNAs in melanoma diagnosis, prognostication, and treatment.
Main Methods:
- Literature review of studies on lncRNAs in melanoma.
- Summary of evidence on the deregulation and function of specific lncRNAs (e.g., HOTAIR, MALAT1, BANCR, ANRIL, SPRY-IT1, SAMMSON) in melanoma.
- Analysis of current and potential clinical applications.
Main Results:
- Numerous lncRNAs are deregulated in melanoma.
- lncRNAs influence key cellular processes critical to melanoma's aggressive phenotype, including proliferation, migration, and invasion.
- Specific lncRNAs have been identified with roles in melanoma pathogenesis.
Conclusions:
- lncRNAs are significant regulators in melanoma.
- lncRNAs hold promise as biomarkers for melanoma diagnosis and prognostication.
- Targeting lncRNAs may offer novel therapeutic strategies for melanoma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Nursing Code of Ethics
Small interfering RNAs (siRNA)

